|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Recro Pharma (NASDAQ: REPH) through any online brokerage.
The latest price target for Recro Pharma (NASDAQ: REPH) was reported by William Blair on October 12, 2021. The analyst firm set a price target for 0.00 expecting REPH to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Recro Pharma (NASDAQ: REPH) is $1.8 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Recro Pharma.
Recro Pharma’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Recro Pharma.
Recro Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.